Journal profile · Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
Clinical and Experimental Neuroimmunology
ISSN 1759-1961 · Wiley-Blackwell
Clinical and Experimental Neuroimmunology: subscription journal; APC about USD 2,710; median 63 days to acceptance (81 articles, last 24 months); acceptance rate 54% (journal website); 63 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Clinical and Experimental Neuroimmunology is published by Wiley-Blackwell. By OpenAlex counts of its recent articles, its largest topics are Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Autoimmune Neurological Disorders and Treatments, together about 52.5% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical and Experimental Neuroimmunology is an international journal sponsored by the Japanese Society for Neuroimmunology and affords a medium for the prompt publication of studies on all areas of clinical and experimental neuroimmunology. It also covers neuroscience, basic immunology, clinical neurology and neurovirology, if the subject matter is targeting the interface between neuroscience and immunology or is relevant for optimizing treatment of neuroimmunological disorders including multiple sclerosis, polymyositis/dermatomyositis, myasthenia gravis, Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. The journal aims to encourage the international exchange of results and encourages authors from all countries to submit in the following six categories: Original Articles, Case Reports, Reviews, Commentaries, Editorials, and Letters to the Editor. Author guide is available via here. Abstracting and Indexing Information Academic OneFile (GALE Cengage) Academic Search Alumni Edition (EBSCO Publishing) Academic Search Elite (EBSCO Publishing) Biomedical Reference Collection (EBSCO Publishing) Biotechnology Source (EBSCO Publishing) Embase (Elsevier) Health Reference Center Academic (GALE Cengage) InfoTrac (GALE Cengage) SCOPUS (Elsevier) STM Source (EBSCO Publishing)
From the journal's Aims & Scope
Research area (LetPub): Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
Editor-in-chief Hiroyuki MuraiPublisher website
Editorial board by country: none in mainland China; most named Japan 25, United States 5, Germany 3, United Kingdom 2, Canada 2 (40 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Multiple Sclerosis Research StudiesMedicine24.8%
- Peripheral Neuropathies and DisordersMedicine18.2%
- Autoimmune Neurological Disorders and TreatmentsMedicine9.6%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience7.9%
- Myasthenia Gravis and ThymomaMedicine5.5%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology4.3%
- Inflammatory Myopathies and DermatomyositisMedicine3.6%
- T-cell and B-cell ImmunologyImmunology and Microbiology3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Immunology and Microbiology (miscellaneous) | Q2 | 22/43 | 50th |
| Neuroscience (miscellaneous) | Q3 | 48/74 | 35th |
| Neurology (clinical) | Q3 | 268/403 | 33rd |
| Immunology | Q4 | 186/243 | 23rd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.4LetPub ·
- CiteScore (publisher) 2025
- 2.4Publisher website ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.36LetPub ·
- h-index
- 28OpenAlex ·
- i10-index
- 101OpenAlex ·
- 2-year mean citedness
- 0.7OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher) 2025
- 51Publisher website ·
- Downloads per year (publisher) 2025
- 64,183Publisher website ·
Articles by year OpenAlex count · 1,021 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 23 | 284 |
| 2025 | 63 | 25 | 410 |
| 2024 | 51 | 32 | 399 |
| 2023 | 42 | 24 | 425 |
| 2022 | 56 | 15 | 453 |
| 2021 | 65 | 15 | 408 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
63 daysMedian, submission to acceptance · P25–P75 24 days – 92 days
- Acceptance to online
- median 14 days (82 articles)
- Submission to online
- median 76 days
- Sample
- 81 articles with submission and acceptance dates (107 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher) 2025
- 54%Publisher website ·
- Submission to first decision 2025
- 18 daysPublisher website ·
- Submission to acceptance 2025
- 53 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,710 / EUR 2,260 / GBP 1,810 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
Article types accepted1
- editorialManuscripts are assigned to the Chief Editor according to the field that the contributor has indicated by submission, but the contributor can also choose a hand…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Preprints, Self-archiving
- AI use Use of AI tools
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), no…
Source ↗Publisher website ·- Authorship Authorship
Authorship policy: follows ICMJE authorship criteria; each author must meet all four criteria (substantial contributions; drafting/revising; final approval; accountability). Model summary
Clinical and Experimental Neuroimmunology follows the recommendations formulated by the International Committee of Medical Journal Editors regarding criteria for authorship. Accordingly, each person listed as an author or coauthor for a submitted manuscript must meet all four criteria. An author or coauthor shall have:
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
Authors must declare any financial support or relationships that may pose a conflict of interest by disclosing at the time of submission any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. This applies to all manuscripts types. The corresponding author should collect all authors COI disclosu…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Data sharing policy: encourages archiving data in a public repository and including a data accessibility statement with a link to the repository. Model summary
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
Source ↗Publisher website ·- License & copyright 8. COPYRIGHT, LICENSING AND OPEN ACCESS
Open access licensing: CC-BY/CC-BY-NC/CC-BY-NC-ND Creative Commons licenses. Model summary
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.Open AccessThis journal i…
Source ↗Publisher website ·- Open access 8. COPYRIGHT, LICENSING AND OPEN ACCESS
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.Open AccessThis journal i…
Source ↗Publisher website ·- Peer review
Peer review policy: single blind peer review. Model summary
The peer review process is single blind.
Source ↗Publisher website ·- Plagiarism Plagiarism Detection
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines.
Source ↗Publisher website ·- Preprints Preprint Policy
Preprint policy: preprints may be submitted; authors should update preprint versions with a link to the final published article and may post the final published version immediately after publication. Model summary
Clinical and Experimental Neuroimmunology will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication. Allowing submission does not, of course, guarantee that an article will be sent out for …
Source ↗Publisher website ·- Self-archiving
Self-archiving allowed under the standard copyright agreement under specific conditions. Model summary
Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- ISSN
- 1759-1961
- Society / sponsor
- Japanese Society for Neuroimmunology
- Latest issue on the website
- Volume 17, Issue 4 (November 2026)
- Official links
- Journal homepage ↗OpenAlex
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinical and Experimental Neuroimmunology
How long does peer review take at Clinical and Experimental Neuroimmunology?
Based on the dates recorded on 81 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 63 days (interquartile range 24–92 days); the journal's website gives an acceptance rate of 54% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical and Experimental Neuroimmunology?
According to the journal's author guidelines: Reference style: Vancouver; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical and Experimental Neuroimmunology based?
Of the 40 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (25), United States (5) and Germany (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical and Experimental Neuroimmunology?
According to LetPub and DOAJ records, Clinical and Experimental Neuroimmunology is indexed in Scopus. The journal's website also lists Embase; that list has not been checked against each database.
Is Clinical and Experimental Neuroimmunology open access, and what is the APC?
Clinical and Experimental Neuroimmunology is a subscription journal. APC about USD 2,710.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .